12-month Sustained Efficacy of Flibanserin v Placebo n Younger Women With HSDD in NA
12-month Sustained Efficacy of Flibanserin v Placebo n Younger Women With HSDD in NA
To estimate the duration of efficacy with continued treatment of double-blind flibanserin or placebo over twenty-four weeks of treatment.
Inclusion Criteria:
Exclusion Criteria: